
Lunch and Learn: What to Know About 409A Valuations
April 30, 2020
Gregg Hamilton-Piercy, The MFA Companies & Kurt Sheline, Echo Health Ventures, will discuss some of the most common valuation methods.
Join Gregg Hamilton-Piercy, CFA, ASA, The MFA Companies, and Kurt Sheline, Echo Health Ventures, for a Lunch and Learn discussion on some of the most common valuation methods being used, the typical investment terms to expect from a venture investor and how the introduction of a new preferred security in an ownership structure can significantly change the share economics afforded to founders. We will also look at how 409A’s impact stock option grants, how to best incentivize your employees, and any considerations to think about when raising venture capital.
Cambia Grove Lunch & Learns, presented by Echo Health Ventures, Intermountain Health Ventures, Epic Ventures and Mountain Pacific Venture Fund takes place twice a month, offering opportunities for entrepreneurs to learn about high-value health care topics while enjoying a mid-day snack.
Hosted by:
Date & time:
Cost:
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp














